level	trait	total_gwas_snps	trait_snps	eqtls_in_catalog	trait_eqtls	pval	adj_pval	sim_count	sim_pval
level0	General cognitive ability	344506	1258	785	13	9.144867993615984e-06	0.0071329970350204	4	0.01
level0	White matter microstructure (mean diusivities)	344506	198	785	17	1.0580264114152539e-21	8.2526060090389815e-19	15	0.032
level0	White matter microstructure (radial diusivities)	344506	250	785	15	5.746357052639971e-17	4.4821585010591774e-14	13	0.028
level0	White matter microstructure (axial diusivities)	344506	160	785	13	1.3042969177039718e-16	1.0173515958090981e-13	4	0.01
level0	White matter microstructure (fractional anisotropy)	344506	240	785	11	1.511149196021486e-11	1.178696372896759e-08	16	0.034
level0	Hemoglobin concentration	344506	1081	785	21	2.1710670651412905e-13	1.6934323108102063e-10	34	0.07
level0	Household income	344506	70	785	4	2.1766432500734216e-05	0.0169778173505726	6	0.014
level0	Neuroticism	344506	1057	785	36	4.1476858845074784e-30	3.235194989915833e-27	15	0.032
level0	Snoring	344506	72	785	4	2.433466931015456e-05	0.0189810420619205	1	0.004
level0	Osteoarthrosis (time to event)	344506	5	785	2	5.162001375072087e-05	0.0402636107255622	6	0.014
level0	Parkinson's disease	344506	374	785	24	5.4497481579531786e-27	4.25080356320348e-24	31	0.064
level0	Warfarin maintenance dose	344506	27	785	3	3.309403299315483e-05	0.0258133457346607	3	0.008
level0	Ovarian cancer in BRCA1 mutation carriers	344506	8	785	3	6.544097572979277e-07	0.0005104396106923	2	0.006
level0	Parkinson's disease or first degree relation to individual with Parkinson's disease	344506	107	785	5	5.320631183528271e-06	0.004150092323152	1	0.004
level0	Cortical surface area (global PC1)	344506	15	785	5	1.787266067601461e-10	1.39406753272914e-07	5	0.012
level0	IDP dMRI TBSS MD Anterior limb of internal capsule R	344506	4	785	2	3.1018991291938e-05	0.0241948132077116	4	0.01
level0	BA-exvivo rh area V2	344506	5	785	2	5.162001375072087e-05	0.0402636107255622	4	0.01
level0	IDP T1 SIENAX brain-unnormalised volume	344506	4	785	2	3.1018991291938e-05	0.0241948132077116	3	0.008
level0	IDP T1 SIENAX white normalised volume	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	2	0.006
level0	IDP T1 SIENAX white unnormalised volume	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	2	0.006
level0	IDP T1 SIENAX brain-normalised volume	344506	4	785	2	3.1018991291938e-05	0.0241948132077116	3	0.008
level0	aparc-Desikan rh area TotalSurface	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	2	0.006
level0	IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L	344506	2	785	2	5.185532968847352e-06	0.0040447157157009	2	0.006
level0	IDP dMRI TBSS L3 Genu of corpus callosum	344506	4	785	2	3.1018991291938e-05	0.0241948132077116	2	0.006
level0	IDP dMRI ProbtrackX MD atr l	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	7	0.016
level0	IDP dMRI TBSS L3 Anterior limb of internal capsule R	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	3	0.008
level0	IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	2	0.006
level0	aparc-Desikan lh area TotalSurface	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	3	0.008
level0	IDP dMRI ProbtrackX L1 ptr l	344506	2	785	2	5.185532968847352e-06	0.0040447157157009	3	0.008
level0	IDP dMRI ProbtrackX L1 str r	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	7	0.016
level0	aseg global volume BrainSegNotVentSurf	344506	3	785	2	1.5533027210684506e-05	0.0121157612243339	3	0.008
level0	aseg global volume SupraTentorialNotVent	344506	2	785	2	5.185532968847352e-06	0.0040447157157009	3	0.008
level0	Alzheimer's disease or family history of Alzheimer's disease	344506	309	785	12	1.240652165226096e-11	9.677086888763551e-09	3	0.008
level0	Family history of Alzheimer's disease	344506	87	785	5	1.9201391377129515e-06	0.0014977085274161	0	0.002
level0	Feeling miserable	344506	64	785	4	1.5247782415498249e-05	0.0118932702840886	6	0.014
level0	Experiencing mood swings	344506	69	785	8	5.188360719477169e-12	4.0469213611921924e-09	8	0.018
level0	Feeling hurt	344506	46	785	5	7.69485276259473e-08	6.0019851548238894e-05	8	0.018
level0	Feeling worry	344506	71	785	5	6.972692594416561e-07	0.0005438700223644	12	0.026
level0	Irritable mood	344506	67	785	8	4.063441591908175e-12	3.169484441688376e-09	12	0.026
level0	Neurociticism	344506	181	785	7	2.473503758488588e-07	0.0001929332931621	1	0.004
level0	Feeling nervous	344506	67	785	5	5.211153200180907e-07	0.0004064699496141	7	0.016
level0	Feeling guilty	344506	29	785	7	4.640179974667452e-13	3.6193403802406116e-10	10	0.022
level0	Feeling fed-up	344506	60	785	4	1.1787202763468236e-05	0.0091940181555052	6	0.014
level0	Alzheimer's disease	344506	342	785	16	2.676741110419628e-16	2.0878580661273106e-13	1	0.004
level0	Depressed affect	344506	157	785	16	9.946551241590649e-22	7.758309968440709e-19	9	0.02
level0	Worry	344506	147	785	9	8.227403857978455e-11	6.417375009223194e-08	10	0.022
level0	General factor of neuroticism	344506	308	785	20	7.836283187426076e-23	6.112300886192339e-20	12	0.026
level0	Alzheimer's disease or gastroesophageal reflux disease	344506	186	785	6	5.1401252712052784e-06	0.0040092977115401	0	0.002
level0	Inguinal hernia	344506	2192	785	23	2.924880816414517e-09	2.2814070368033235e-06	11	0.024
level0	Schizophrenia or ER positive breast cancer (pleiotropy)	344506	17	785	3	7.825595251269117e-06	0.0061039642959899	3	0.008
level0	Suicidal thoughts and behaviors	344506	21	785	3	1.5202158488385569e-05	0.0118576836209407	3	0.008
level0	Posterolateral temporal area (unadjusted for global measures)	344506	33	785	4	1.0386547828863151e-06	0.0008101507306513	8	0.018
level0	Dorsomedial frontal area (unadjusted for global measures)	344506	54	785	5	1.748744378721086e-07	0.0001364020615402	3	0.008
level0	Parsopercularis area (unadjusted for global measures)	344506	46	785	4	4.0456991425259614e-06	0.0031556453311702	4	0.01
level0	Occipital area (unadjusted for global measures)	344506	45	785	4	3.700590389878087e-06	0.0028864605041049	8	0.018
level0	Middle temporal thickness (unadjusted for global measures)	344506	23	785	4	2.288727921892947e-07	0.0001785207779076	3	0.008
level0	Anteromedial temporal area (unadjusted for global measures)	344506	29	785	4	6.072461919585532e-07	0.0004736520297276	3	0.008
level0	Dorsolateral prefrontal area (unadjusted for global measures)	344506	48	785	5	9.576014900599146e-08	7.469291622467334e-05	5	0.012
level0	COVID-19 severity	344506	47	785	7	1.8044134543979095e-11	1.4074424944303697e-08	12	0.026
level0	Motor premotor area (unadjusted for global measures)	344506	39	785	5	3.2749927965234495e-08	2.5544943812882904e-05	7	0.016
level0	Inferior parietal area (unadjusted for global measures)	344506	45	785	5	6.871393646666247e-08	5.359687044399673e-05	7	0.016
level0	Dorsolateral prefrontal thickness (unadjusted for global measures)	344506	23	785	4	2.288727921892947e-07	0.0001785207779076	2	0.006
level0	Superior parietal area (unadjusted for global measures)	344506	30	785	4	6.994002672639423e-07	0.0005455322084658	11	0.024
level0	Medial temporal thickness (unadjusted for global measures)	344506	15	785	3	5.254093427160239e-06	0.0040981928731849	2	0.006
level0	Inferior parietal thickness (unadjusted for global measures)	344506	21	785	4	1.5525459299148833e-07	0.0001210985825333	4	0.01
level0	Ventromedial occipital thickness (unadjusted for global measures)	344506	32	785	4	9.144122180681948e-07	0.0007132415300931	4	0.01
level0	Ventral frontal thickness (unadjusted for global measures)	344506	29	785	4	6.072461919585532e-07	0.0004736520297276	4	0.01
level0	Post-traumatic stress disorder symptom severity (total)	344506	26	785	3	2.9466955257170127e-05	0.0229842251005926	2	0.006
level0	Breast cancer or hospitalized COVID-19 (pleiotropy)	344506	7	785	3	4.0970328787166666e-07	0.0003195685645399	5	0.012
level0	Breast cancer or critical COVID-19 (pleiotropy)	344506	6	785	3	2.345152820279049e-07	0.0001829219199817	5	0.012
level0	Ovarian cancer or hospitalized COVID-19 (pleiotropy)	344506	6	785	3	2.345152820279049e-07	0.0001829219199817	7	0.016
level0	Ovarian cancer or critical COVID-19 (pleiotropy)	344506	4	785	3	4.7063138827677504e-08	3.670924828558845e-05	8	0.018
level1	White matter microstructure (mean diusivities)	344506	198	517	12	4.81303872180506e-16	2.45464974812058e-13	10	0.022
level1	White matter microstructure (radial diusivities)	344506	250	517	9	2.37631420829844e-10	1.2119202462322042e-07	11	0.024
level1	White matter microstructure (axial diusivities)	344506	160	517	8	1.7795455834301898e-10	9.07568247549397e-08	4	0.01
level1	Cortical thickness	344506	632	517	8	6.5031110076283446e-06	0.0033165866138904	6	0.014
level1	Intracranial volume	344506	9	517	2	8.035636803147128e-05	0.0409817476960503	4	0.01
level1	White matter microstructure (fractional anisotropy)	344506	240	517	8	4.360304218121706e-09	2.22375515124207e-06	9	0.02
level1	Hemoglobin concentration	344506	1081	517	13	1.6251654875345564e-08	8.288343986426238e-06	21	0.044
level1	Household income	344506	70	517	4	4.249489646799812e-06	0.0021672397198679	4	0.01
level1	Neuroticism	344506	1057	517	23	1.812485220853273e-19	9.243674626351692e-17	20	0.042
level1	Osteoarthrosis (time to event)	344506	5	517	2	2.2410367598162427e-05	0.0114292874750628	4	0.01
level1	Parkinson's disease	344506	374	517	18	1.4323654084298113e-21	7.305063582992038e-19	19	0.04
level1	Ovarian cancer in BRCA1 mutation carriers	344506	8	517	3	1.87119056522126e-07	9.543071882628426e-05	4	0.01
level1	Cortical surface area (global PC1)	344506	15	517	4	6.754147648039427e-09	3.444615300500108e-06	4	0.01
level1	Corticobasal degeneration	344506	6	517	2	3.358206238095586e-05	0.0171268518142874	4	0.01
level1	IDP dMRI TBSS MD Anterior limb of internal capsule R	344506	4	517	2	1.345963116557692e-05	0.0068644118944442	4	0.01
level1	IDP dMRI TBSS ICVF Anterior corona radiata R	344506	8	517	2	6.256170056946592e-05	0.0319064672904276	4	0.01
level1	IDP dMRI TBSS ICVF Posterior limb of internal capsule R	344506	8	517	2	6.256170056946592e-05	0.0319064672904276	4	0.01
level1	BA-exvivo rh area V2	344506	5	517	2	2.2410367598162427e-05	0.0114292874750628	4	0.01
level1	IDP T1 SIENAX brain-unnormalised volume	344506	4	517	2	1.345963116557692e-05	0.0068644118944442	4	0.01
level1	IDP T1 SIENAX white normalised volume	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP T1 SIENAX white unnormalised volume	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP T1 SIENAX brain-normalised volume	344506	4	517	2	1.345963116557692e-05	0.0068644118944442	4	0.01
level1	aparc-Desikan rh area TotalSurface	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L	344506	2	517	2	2.2477495793479858e-06	0.0011463522854674	4	0.01
level1	IDP dMRI TBSS L3 Genu of corpus callosum	344506	4	517	2	1.345963116557692e-05	0.0068644118944442	4	0.01
level1	IDP dMRI ProbtrackX MD atr l	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP dMRI TBSS L3 Anterior limb of internal capsule R	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP dMRI ProbtrackX ICVF atr r	344506	6	517	2	3.358206238095586e-05	0.0171268518142874	4	0.01
level1	aparc-Desikan lh area TotalSurface	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	IDP dMRI ProbtrackX L1 ptr l	344506	2	517	2	2.2477495793479858e-06	0.0011463522854674	4	0.01
level1	IDP dMRI ProbtrackX L1 str r	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	aseg global volume BrainSegNotVentSurf	344506	3	517	2	6.736528401421756e-06	0.003435629484725	4	0.01
level1	aseg global volume SupraTentorialNotVent	344506	2	517	2	2.2477495793479858e-06	0.0011463522854674	4	0.01
level1	Serum levels of protein CHL1	344506	3	517	2	6.736528401421756e-06	0.003435629484725	5	0.012
level1	Feeling miserable	344506	64	517	4	2.965819901649916e-06	0.0015125681498414	4	0.01
level1	Experiencing mood swings	344506	69	517	7	1.6385712956128668e-11	8.35671360762562e-09	4	0.01
level1	Feeling hurt	344506	46	517	5	9.726668934016473e-09	4.9606011563484015e-06	4	0.01
level1	Feeling worry	344506	71	517	5	8.95737996087591e-08	4.5682637800467145e-05	6	0.014
level1	Irritable mood	344506	67	517	7	1.324199718423626e-11	6.753418563960493e-09	5	0.012
level1	Feeling guilty	344506	29	517	5	8.605901845644659e-10	4.389009941278776e-07	5	0.012
level1	Feeling fed-up	344506	60	517	4	2.2870405670410525e-06	0.0011663906891909	4	0.01
level1	Feeling nervous	344506	67	517	4	3.5650554160044656e-06	0.0018181782621622	6	0.014
level1	Maximum habitual alcohol consumption	344506	50	517	3	6.24886958536238e-05	0.0318692348853481	4	0.01
level1	Depressed affect	344506	157	517	10	8.160298028171953e-14	4.1617519943676946e-11	6	0.014
level1	Worry	344506	147	517	5	3.344769855151094e-06	0.001705832626127	24	0.05
level1	General factor of neuroticism	344506	308	517	15	2.7729139821237133e-18	1.4141861308830938e-15	4	0.01
level1	Alzheimer's disease (age of onset) in APOE e4 non-carriers	344506	9	517	2	8.035636803147128e-05	0.0409817476960503	4	0.01
level1	Cognitive aspects of educational attainment	344506	260	517	5	5.191418962616995e-05	0.0264762367093466	2	0.006
level1	Schizophrenia or ER positive breast cancer (pleiotropy)	344506	17	517	3	2.249393923864195e-06	0.0011471909011707	4	0.01
level1	Posterolateral temporal area (unadjusted for global measures)	344506	33	517	4	1.9818188790951365e-07	0.0001010727628338	4	0.01
level1	Dorsomedial frontal area (unadjusted for global measures)	344506	54	517	4	1.4938575846648225e-06	0.000761867368179	18	0.038
level1	Parsopercularis area (unadjusted for global measures)	344506	46	517	3	4.8613384092098754e-05	0.0247928258869703	20	0.042
level1	Occipital area (unadjusted for global measures)	344506	45	517	4	7.113741763770242e-07	0.0003628008299522	10	0.022
level1	Orbitofrontal area (unadjusted for global measures)	344506	41	517	3	3.4329340037153426e-05	0.0175079634189482	20	0.042
level1	Middle temporal thickness (unadjusted for global measures)	344506	23	517	4	4.3399816806269684e-08	2.2133906571197537e-05	4	0.01
level1	Anteromedial temporal area (unadjusted for global measures)	344506	29	517	3	1.1926099245062235e-05	0.0060823106149817	10	0.022
level1	Dorsolateral prefrontal area (unadjusted for global measures)	344506	48	517	5	1.2120221147184432e-08	6.18131278506406e-06	19	0.04
level1	COVID-19 severity	344506	47	517	7	9.827665428893465e-13	5.012109368735667e-10	4	0.01
level1	Motor premotor area (unadjusted for global measures)	344506	39	517	5	4.121038665519225e-09	2.101729719414805e-06	10	0.022
level1	Inferior parietal area (unadjusted for global measures)	344506	45	517	4	7.113741763770242e-07	0.0003628008299522	19	0.04
level1	Superior temporal area (unadjusted for global measures)	344506	39	517	3	2.94969317583819e-05	0.0150434351967747	20	0.042
level1	Dorsolateral prefrontal thickness (unadjusted for global measures)	344506	23	517	4	4.3399816806269684e-08	2.2133906571197537e-05	4	0.01
level1	Precuneus area (unadjusted for global measures)	344506	34	517	3	1.942205421276988e-05	0.0099052476485126	20	0.042
level1	Superior parietal area (unadjusted for global measures)	344506	30	517	4	1.332015203664331e-07	6.793277538688088e-05	10	0.022
level1	Medial temporal thickness (unadjusted for global measures)	344506	15	517	3	1.5084802157086455e-06	0.0007693249100114	4	0.01
level1	Inferior parietal thickness (unadjusted for global measures)	344506	21	517	4	2.940342895805815e-08	1.4995748768609655e-05	4	0.01
level1	Ventromedial occipital thickness (unadjusted for global measures)	344506	32	517	4	1.743672857683047e-07	8.89273157418354e-05	4	0.01
level1	Ventral frontal thickness (unadjusted for global measures)	344506	29	517	4	1.1557884165074121e-07	5.894520924187802e-05	4	0.01
level1	Post-traumatic stress disorder symptom severity (total)	344506	26	517	3	8.514505462194896e-06	0.0043423977857193	4	0.01
level1	Breast cancer or hospitalized COVID-19 (pleiotropy)	344506	7	517	3	1.1708038567638929e-07	5.971099669495853e-05	4	0.01
level1	Breast cancer or critical COVID-19 (pleiotropy)	344506	6	517	3	6.6978009818165e-08	3.415878500726415e-05	4	0.01
level1	Ovarian cancer or hospitalized COVID-19 (pleiotropy)	344506	6	517	3	6.6978009818165e-08	3.415878500726415e-05	4	0.01
level1	Ovarian cancer or critical COVID-19 (pleiotropy)	344506	4	517	3	1.3425628556642069e-08	6.847070563887454e-06	4	0.01
level1	Major depressive disorder or severe COVID-19 (pleiotropy)	344506	7	517	2	4.6968055236076585e-05	0.023953708170399	4	0.01
level1	Major depressive disorder or hospitalized COVID-19 (pleiotropy)	344506	6	517	2	3.358206238095586e-05	0.0171268518142874	4	0.01
level2	Esophageal squamous cell carcinoma	344506	44	153	2	0.0001831077993294	0.0346073740732731	0	0.002
level2	Esophageal cancer and gastric cancer	344506	4	153	2	1.1750060656970654e-06	0.0002220761464167	1	0.004
level2	Basophil percentage of white cells	344506	217	153	3	0.0001345347624118	0.025427070095831	0	0.002
level2	Uridine levels	344506	12	153	4	1.84597799563466e-11	3.4888984117495076e-09	19	0.04
level2	5-methyluridine (ribothymidine) levels	344506	20	153	5	2.494189345069914e-13	4.714017862182138e-11	23	0.048
level3	Platelet count	344506	3349	331	12	0.0001205960070591	0.0372641661812918	20	0.042
level3	Coronary artery disease	344506	1580	331	10	4.032465780844238e-06	0.0012460319262808	36	0.074
level3	Platelet distribution width	344506	771	331	6	0.0001162308974974	0.0359153473267054	13	0.028
level3	Placenta growth factor levels	344506	19	331	2	0.000155684956233	0.0481066514760138	0	0.002
level3	Lysozyme C levels	344506	6	331	2	1.3770022521422483e-05	0.0042549369591195	20	0.042
level3	Orotate levels	344506	11	331	4	2.746862067540944e-10	8.487803788701518e-08	24	0.05
level4	Hemoglobin concentration	344506	1081	895	12	3.551052554482877e-05	0.0277692309760561	120	0.242
level4	Mean corpuscular hemoglobin	344506	2366	895	26	1.6284314485835431e-09	1.2734333927923309e-06	134	0.269
level4	Mean corpuscular hemoglobin concentration	344506	738	895	10	3.0504070478097352e-05	0.0238541831138721	26	0.054
level4	Mean corpuscular volume	344506	2227	895	26	4.685268085188176e-10	3.663879642617154e-07	95	0.192
level4	Red blood cell count	344506	2964	895	22	1.65242895145095e-05	0.0129219944003464	45	0.092
level4	Urolithiasis	344506	63	895	4	2.385933386000844e-05	0.0186579990785265	26	0.054
level4	Total body bone mineral density	344506	205	895	8	8.636866150723014e-08	6.754029329865397e-05	59	0.12
level4	N-acetylhistidine levels	344506	18	895	4	1.3450311324638784e-07	0.0001051814345586	18	0.038
level4	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	344506	5	895	3	1.7407530129932597e-07	0.000136126885616	56	0.114
